Rezafungin for fungal infection in the belly
Part of Infections clinical trials.
This trial tests how well rezafungin, an antifungal medicine, spreads in belly fluid when given during surgery for a suspected fungal infection in the abdomen. It aims to see if it's a good treatment option for patients needing abdominal surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have a suspected fungal infection in your belly that needs surgery
- You will get rezafungin as your first antifungal treatment right before or within 1 hour of surgery
- You will have a drain in your belly for at least 2 days after surgery
- You are not expected to die within 24 hours
- You agree to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial monitors a marker of immune function (monocyte HLA-DR) in patients with severe abdominal infections that may lead to fungal infections. It aims to see if this marker can help guide treatment.
This trial tests whether a shorter course of the antifungal caspofungin (7 days total) is as effective as the usual longer treatment for people with uncomplicated candidemia, a yeast infection in the blood. Participating patients must already be on caspofungin and have shown clear blood cultures for 7 days.
This trial is testing how the body processes the antifungal drug rezafungin in people who may have a fungal infection in their abdomen (peritonitis or intra-abdominal candidiasis). It aims to understand how the drug works and if it can help when other antibiotics haven't worked.
This trial tests whether a medicine called rezafungin can help prevent serious fungal infections in people who have received a liver transplant. If you have certain risk factors, this study may offer extra protection against infections.
This Phase 3 trial studies whether caspofungin (an antifungal medicine) helps treat suspected or confirmed yeast (candidiasis) infections inside the abdomen in ICU patients after surgery. You would either receive caspofungin or a placebo, and the goal is to see which option works better and is safe.
This Phase 2 trial tests rezafungin, an antifungal medicine, to treat Pneumocystis pneumonia (PCP) in adults living with HIV. It may help people recover faster or more effectively from this serious lung infection.
Hear when a new Abdominal Surgery Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.